PS14-02: A randomised phase IB/IIA study of CApecitabine plus Radium-223 in breast cancer patients with BONe metastases (CARBON) - Safety and preliminary efficacy findings

Winter, M, Kendall, J, Brown, S orcid.org/0000-0002-7975-7537 et al. (9 more authors) (2021) PS14-02: A randomised phase IB/IIA study of CApecitabine plus Radium-223 in breast cancer patients with BONe metastases (CARBON) - Safety and preliminary efficacy findings. In: 2020 San Antonio Breast Cancer Virtual Symposium, 08-11 Dec 2020, San Antonio, Texas, USA.

Metadata

Authors/Creators:
Dates:
  • Published: February 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 30 Mar 2021 12:39
Last Modified: 30 Mar 2021 12:39
Status: Published
Identification Number: https://doi.org/10.1158/1538-7445.SABCS20-PS14-02
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics